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Current cervical total disc replacement (TDR) designs incorporate a variety of different biomaterials including polyethylene,
stainless steel, titanium (Ti), and cobalt-chrome (CoCr).These materials are most important in their utilization as bearing surfaces
which allow for articular motion at the disc space. Long-term biological effects of implanted materials include wear debris, host
inflammatory immune reactions, and osteolysis resulting in implant failure. We review here the most common materials used in
cervical TDRprosthetic devices, examine their bearing surfaces, describe the construction of the seven current cervical TDRdevices
that are approved for use in the United States, and discuss known adverse biological effects associated with long-term implantation
of these materials. It is important to appreciate and understand the variety of biomaterials available in the design and construction
of these prosthetics and the considerations which guide their implementation.
1. Introduction
Total disc replacement (TDR) was initially developed as an
alternative to fusion with the aim of preserving segmental
motion. Cervical TDR has been used following an anterior
discectomy for the treatment of radiculopathy or myelopa-
thy. Although the anterior cervical discectomy and fusion
(ACDF) has been successful with regard to overall outcome,
fusion does lead to increased biomechanical stress at adjacent
segments thatmay then accelerate degeneration at these levels
[1–5]. Arthroplasty preserves themotion at the operated level
and should reduce the rate of adjacent level pathology as well
as avoid any complications associated with pseudoarthrosis.
The past several years have seen the continued research
and development of suitable materials for arthroplasty. Cur-
rent cervical TDR designs constitute a wide range of bio-
materials available for their construction.The most common
design used includesmetallic endplates which are fixed to the
vertebral bodies above and below, with one or more articula-
tions that involvemetal-on-metal or metal-on-polymer bear-
ing surfaces at the central core [6]. A broad range of materials
are used in the cervical spine and include polyethylene,
cobalt-chrome (CoCr) alloys, stainless steel, titanium (Ti)
alloys, polyurethanes, and Ti alloy-ceramic composites. The
choice of biomaterials utilized in these prosthetic implants
centers around their sufficient durability, biocompatibility,
and resistance to mechanical loading during physiologic use
[7].
In this paper, we provide a review of the biomaterials used
in cervical TDR devices, describe the type of bearing designs
and their material considerations, review the construction
of the seven current cervical TDR prosthetic implants that
are approved for use in the United States by the Food and
Drug Administration (FDA), and describe known adverse
biological effects associated with the implantation of these
materials.
2. Materials
The choice of materials used in a prosthesis takes into
consideration those used in the articulation surfaces as well
as outer surfaces of the prosthesis that interface with the
endplates of the vertebral bodies themselves. The bearing
surfaces must be made of materials to tolerate loading
without fatigue or fracture, minimize friction, have superior
wear characteristics, and minimize the generation of wear
debris [8].
Articular surfaces may use components made from
polymers such as ultrahigh molecular weight polyethylene
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(UHMWPE). Metals also play a key role in implant design
and creation. Metallic components have been utilized which
may wear more slowly than UHMWPE and include stainless
steel, titanium (Ti), and cobalt-chrome (CoCr) alloy.
Although the initial stability of an artificial disc depends
on soft tissue tensioning and implant design and geometry,
long-termfixation depends on bony ingrowth into the surface
of the prosthesis. Surface coatings have been used to improve
this type of bony ingrowth and include titanium wire mesh,
plasma-sprayed titanium, porous CoCr, and bioactive mate-
rials such as hydroxyapatite and calcium phosphate [4, 9].
2.1. Polyethylene. The use of polyethylene polymer is based
on its prior extensive use and support in knee and hip
arthroplasties [7, 10, 11]. Polyethylene itself is a thermo-
plastic polymer consisting of long hydrocarbon chains with
excellent chemical resistance. Ultrahigh molecular weight
polyethylene (UHMWPE) has extremely long chains with a
molecular mass usually between 2 and 6 million units. The
longer chains allow for more effective load transfers to the
polymer backbone, resulting in a very high impact strength.
UHMWPEwas first used clinically in 1962 by Sir Charnley in
which he incorporated a UHMWPE acetabular cup against a
stainless steel femoral head for use as a total hip replacement
[12].
Overthepastseveraldecades,highly cross-linkedUHMWPE
materials have been introduced and have become the stan-
dard of care for hip arthroplasty [7, 10]. Cross-linking of
polyethylene improves wear resistance and the risk of oste-
olysis in the hip but comes with some concomitant decrease
in mechanical properties [11].
2.2. Stainless Steel. Steels are alloys of iron and other ele-
ments, primarily carbon. Stainless steel is a steel alloy with
a minimum of 10.5% chromium content by mass. As such,
it does not readily corrode, rust, or stain as ordinary steel.
Marine grade stainless 316 steel is a molybdenum-alloyed
steel that is negligibly responsive to magnetic fields and is
the preferred grade steel for medical implantation due to its
immunity from sensitization [13].
The use of stainless steel as a material for cervical
arthroplasty can be traced to the original Bristol/Cummins
disc used in 1991. In the 1980s, British neurosurgeon Brian
Cummins was intent on developing a solution to adjacent
segment disease and collaborated with a medical engineer
to create a ball-and-socket prosthetic for use in the cervical
spine. This became the Bristol/Cummins disc, manufactured
from 316 stainless steel at his hospital’s machine shop. In all,
22 devices were implanted in a total of 20 patients and long-
term follow-up out to 12 years postoperatively demonstrated
these devices to still be functional [14–16].
Though stainless steel has long been used as surgical
implants for many orthopedic applications, it may not always
be preferred in cervical arthroplasties because of its inferior
mechanical properties [4]. Newer metals such as titanium
(Ti) and cobalt-chrome alloy (CoCr) have improved yield
strengths and are less prone to corrosion and fatigue failure
[17].
2.3. Titanium. Titanium is a low-density transition metal
with high strength and is highly resistant to corrosion. Tita-
nium can be alloyed with multiple other metals such as iron,
aluminum, vanadium, and molybdenum to create strong,
lightweight alloys for use in a variety of industries. Because
of its biocompatibility, it is an ideal substance for medical
implantation of prosthetics and is often alloyed with 4–6%
aluminum and 4% vanadium [18].
Titanium has an inherent ability for osseointegration
which stems from its lower modulus of elasticity (Young’s
modulus) to more closely match that of bone for greater
mechanical compatibility [18]. Studies have shown the capac-
ity for bone to bond directly with pure titanium without
need for an intervening membrane or scaffold [19–21]. This
observation has led to the development of porous titanium
spray-coatings on the outer surfaces of cervical prosthetic
implants for long-term bony fixation in the cervical spine.
This effect is even more significant when hydroxyapatite is
applied as well [18, 21].
Titanium alloys have not been used in arthroplasty artic-
ulating components due to their poor wear characteristics
[4, 18, 22, 23]. Laboratory studies have shown that implanted
titanium used as a bearing surface wears down at a higher
rate than either stainless steel or cobalt-chrome because of its
poor abrasion resistance qualities [17, 24, 25]. The generation
of polyethylene wear debris is also the greatest with titanium,
and the least with cobalt-chrome [17, 24, 26–28]. Titanium
is more prone to abrasive wear due to its surface oxide layer;
treating the surface of titanium with nitride or diamond-like
carbon, however, improves hardness and wear characteristics
while still offering the same MRI imaging compatibility [4,
29, 30]. Even with this supplementation, however, its wear
properties still remain inferior to cobalt-chrome or ceramic
surfaces [18].
2.4. Cobalt-Chrome. Cobalt-chrome (CoCr) is a metal alloy
of cobalt and chromium with a very high specific strength
and approximately twice the stiffness of titanium [18]. The
alloy composition used to make prosthetics for surgical
implantation typically contains 5–7% molybdenum and is
therefore sometimes referenced as being made of cobalt-
chromium-molybdenum (CoCrMo). Due to their corrosion
resistance and excellent biocompatibility, CoCr alloys pose
little risk of irritation, allergic reaction, or immune response
[31, 32]. This is in part due to the spontaneous formation
of a chromium-oxide surface film during its synthesis which
renders it biocompatible with physiological environments.
Harold Bohlman is credited with designing the first cor-
rosion-resistant cobalt-chrome alloy femoral head replace-
ment for use as a femoral head prosthetic in 1937 [33]. Since
then, CoCr alloys have shown excellent wear characteristics
as successfully demonstrated through their wide utilization
in joint arthroplasties. Multiple studies have demonstrated
CoCr’s high resistance to wear especially as compared with
titanium alloy [17, 27, 28]. These alloys have seen extensive
use as bearing surfaces due to these proven properties [4].
CoCr is also particularly favored as a bearing surface due to
reports of reduced amount of metal and polyethylene debris
when compared with titanium [17, 22, 23, 34–39].
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2.5. MRI Characteristics. All TDR designs are safe and
compatible for themagnetic field ofMRI scans.Their greatest
effect on MRI, however, is in the potential imaging inter-
ference that they may cause from any magnetic properties
of their constituent metals [40]. The interference artifact in
patients with metallic implants is due to the large differences
inmagnetic properties of human tissue and implantedmetals
[41, 42]. Depending on the ferromagnetic properties of the
metal, these alloys can produce a significant amount of
this distortion artifact that may confound interpretation of
important anatomic structures near the TDR device such
as the spinal canal, neural foramen, disc spaces, vertebral
bodies, and paraspinal tissues.
The polyethylene component of a cervical TDR produces
no artifact due to its nonmetallic thermoplastic polymer
composition. However, the more common metal compo-
nents of stainless steel, titanium, and cobalt-chrome will all
produce varying degrees of magnetic susceptibility artifact.
Prior craniomaxillofacial studies have found titanium to be
superior to both CoCr alloy and stainless steel with regard
to distortion artifact in the face, head, and neck, but it was
unclear if these conclusions would be applicable to spinal
anatomy [43–45]. Knott et al. investigated the differences
in magnetic and radiographic imaging artifact in posterior
spinal instrumentation containing stainless steel, titanium,
or CoCr alloy [46]. They found that stainless steel implants
produced the most artifact but that there were no significant
differences in diagnostic evaluation between titanium and
CoCr alloy as evaluated by a radiologist and orthopedic
surgeon using a 3.0 Tesla magnetic resonance scanner.
3. Bearing Types
Most TDR designs utilize bearings that are configured with
ball-and-socket surfaces which then articulate with each
other to provide motion. The mechanical load transfer
through this joint, however, leads to friction which can lead
to implant fixation failure as well as the generation of wear
debris [8, 47]. The choice of materials for these TDR bearing
surfaces then continues to be an area of extreme importance
to minimize the friction between the two bearing surfaces
and decrease these risks [47, 48]. The type of bearing used
in the majority of TDRs currently is either that of a metal-
on-polymer design or that of a metal-on-metal design [7].
3.1. Metal-on-Polymer. Bearing surface technology for total
joint arthroplasties traces their origins to the hip and has
evolved over decades of major industrial and scientific
advancement [10, 49]. Sir Charnley developed the initial hip
arthroplasty which used ametal femoral head that articulated
with a high-density polyethylene cup inserted into the acetab-
ulum [47, 50]. This allowed for his idea of a “low friction
arthroplasty” to counteract what he saw as unacceptable
levels of frictional torque of existingmetal-on-metal articular
designs of that time. The standard contemporary total hip
arthroplasty bearings now are based on a metal-on-polymer
design utilizing a CoCr alloy femoral head which articulates
with a UHMWPE acetabular socket.
Metal-on-polymer articulations have the foundation of
extensive clinical experience and literature support as a
bearing surface for multiple joints [10, 49]. The majority of
cervical TDR implants that are FDA-approved for use in
the United States incorporate iterations of metal alloy-based
superior and inferior prosthetic endplates which articulate
with a central polymer core.
3.2. Metal-on-Metal. Metal-on-metal articulation designs
were initially thought to be a viable alternative to metal-on-
polymer devices to reduce long-term wear. These bearing
designs also generate less friction on movement which can
lower the volume of wear debris as compared to polyethylene
type articulations, potentially reducing local inflammation
and osteolysis [6].
The metal-on-metal bearing design was first widely used
in the early 1960s with total hip arthroplasty via the McKee-
Farrar prosthesis. This first generation total hip replacement
utilized cobalt-chrome metal bearing surfaces on both the
femoral and acetabular components [51]. Although early
results were favorable, this design became unpopular due to
possible metal hypersensitivities and ion toxicities [49, 52–
54]. Newer contemporary metal-on-metal hip articulations
were subsequently developed with different CoCr alloys, but
these have also comeunder recent scrutiny due to unexpected
failures and accelerated wear [6, 38, 55–57].
Because the biomechanical forces seen in the hip joint
differ than those in the spine with regard to load as well as
bearing surface conformational constraints, it is still unclear
how these metal-on-metal designs will truly translate with
long-term use in the cervical compartment [49].
4. Cervical Prosthetic Devices
There are currently seven cervical artificial disc replacements
that are approved for use in the United States by the Food
andDrugAdministration (FDA).Theirmaterials and bearing
types will be discussed further here (Table 1).
4.1. Medtronic Prestige ST/Prestige LP. The original Med-
tronic Prestige ST (Medtronic Sofamor Danek, Memphis,
TN, USA) artificial disc utilizes a superior stainless steel
convex ball that articulates with an inferior stainless steel
concave trough. This design built upon and refined the orig-
inal Bristol/Cummins artificial disc, replacing the inferior
hemispherical cup with a shallow ellipsoidal saucer to permit
more translation. Since that metal-on-metal original design,
the product has undergone multiple evolutions with the FDA
recently approving the Prestige LP device in 2014 for use
here in the United States. The Prestige LP retains the same
ball-and-trough socket design but the implant itself utilizes a
proprietary titanium-ceramic composite material. A plasma-
spray titanium coating on the outer surface encourages bony
growth into the device.
4.2. Depuy-Synthes ProDisc-C. The Depuy-Synthes ProDisc-
C (Synthes Spine, Paoli, PA, USA) prosthesis is an adaptation
using the same design as the lumbar total disc replacement
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Table 1: Cervical artificial disc replacements FDA-approved for use in the United States.
Device Manufacturer Bearing type Materials Year FDA-approved
Prestige ST Medtronic MoM Stainless steel 2007
ProDisc-C Depuy-Synthes MoP CoCr, UHMWPE 2007
Bryan Medtronic MoP Ti, PCU 2009
SECURE-C Globus MoP CoCr, UHMWPE 2012
PCM NuVasive MoP CoCr, UHMWPE 2012
Mobi-C LDR MoP CoCr, UHMWPE 2013
Prestige LP Medtronic MoM Ti-ceramic 2014
FDA: Food andDrug Administration;MoM:metal-on-metal; MoP:metal-on-polymer; CoCr: cobalt-chromium alloy; UHMWPE: ultrahighmolecular weight
polyethylene; Ti: titanium alloy; PCU: polycarbonate urethane.
ProDisc-L created by the same company. The articular sur-
faces used include a UHMWPE inlay ball locked into the
inferior endplate which articulates with a CoCr alloy socket
in the superior endplate. The outer coating incorporates a
porous plasma-sprayed titanium coating to encourage bony
growth for long-term stability.
4.3. Medtronic Bryan. The Medtronic Bryan (Medtronic
Sofamor Danek, Memphis, TN, USA) artificial disc consists
of a pair of superior and inferior identical titanium (Ti) shells
that conform to and articulate with a central polycarbonate
urethane (PCU) core. A flexible polyether urethane (PEU)
sheath then surrounds the core to prevent tissue ingrowth
into the articulating surfaces.
Titanium alloy seal plugs help to retain a sterile saline
lubricant. Long-term stability of the implant within the
cervical spine is achieved with bony growth into porous-
coated titanium alloy end plates.
4.4. LDR Mobi-C. The LDR Mobi-C cervical artificial disc
(LDR USA, Austin, TX, USA) uses a three-piece design with
CoCr alloy superior and inferior endplates which encase
a UHMWPE mobile bearing core insert. The endplates
themselves are coated with a plasma-sprayed titanium and
hydroxyapatite coating for long-term fixation within the
cervical spine.
4.5. Globus SECURE-C. The Globus SECURE-C prosthesis
(Globus Medical, Audubon, PA, USA) also uses a three-
piece design with two CoCr alloy endplates. The UHMWPE
central core articulates with the superior CoCr endplate via
a spherical surface and interfaces with the inferior CoCr
endplate through a cylindrical surface. The outer portions of
the CoCr alloy endplates use a titanium plasma-spray coating
for bony ongrowth.
4.6. NuVasive PCM. The PCM (porous-coated motion) cer-
vical artificial disc was initially developed by Cervitech
(Cervitech, Rockaway, NJ, USA) and subsequently acquired
by NuVasive (NuVasive, San Diego, CA, USA). The PCM
disc replacement’s superior and inferior endplates are made
entirely of CoCr alloy while a UHMWPE central core is
locked into the inferior endplate for articulation with the
superior endplate.The articulating surface extends across the
entire bearing and allows for a larger radius of movement and
increased translation during the rotational arc. A titanium
calcium phosphate coating is electrochemically applied to
the outer surface of the superior and inferior CoCr alloy
endplates to allow for bony growth by the vertebral bodies
into the prosthesis.
5. Adverse Biologic Effects
Although all cervical prosthetics are constructed with mate-
rials that are biocompatible for implantation, the long-
term effects of these materials have become more clinically
relevant as more follow-up has been achieved. Wear debris is
generated over time as the articulating surfaces move against
each other, and this debris can subsequently lead to multi-
ple adverse effects including inflammatory hypersensitivity
reactions, pseudotumor formation, osteolysis, and implant
loosening.
5.1. Wear Debris. Generation of wear debris in artificial
joints has been shown to be the primary source of implant
degradation, and the subsequent tissue and inflammatory
reaction to the debris significantly limits the longevity of the
prosthesis [4].This debris has been associated with osteolysis,
implant loosening, and subsequent prosthesis failure [4, 37,
38]. Polyethylene-on-metal provides a low friction surface
contact but generates polyethylene wear debris that in the
literature has been established as a cause of hip and knee
arthroplasty failure. Cross-linking with gamma irradiation
has been used to improve those properties in ultrahigh
molecular weight polyethylene but with some effect to its
mechanical properties [58, 59]. Metal-on-metal articulations
lower wear rates dramatically but still generate a lower
volume through higher quantity of smaller particle debris.
Metal-on-metal designs also provide less shock absorption
than metal-on-polyethylene [4].
Host reaction to wear debris is related to particle shape,
quantity, volume, and concentration [49, 60].Metal-on-metal
articulations produce a predominance of needle-shaped par-
ticles which have been associated with greater inflammation
from prior observations in polyethylene debris [61–64].Wear
debris from metal-on-metal bearings can also form corro-
sion products and molecular complexes [49, 65, 66]. Wear
debris particles are readily phagocytosed by inflammatory
cells, which in turn trigger proinflammatory cascades and
oxidative stress. An individual patient’s response to this debris
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is also unpredictable, with some tolerating it well and others
poorly [67, 68]. All bearing surfaces will produce wear debris,
but poorly positioned or otherwise compromised prosthetics
may produce further pathologic wear [49, 69, 70].
5.2. Immune Response. Polyethylene materials have been
used for decades and have since become the standard of
care in hip arthroplasty [10]. However, it has long been
known that wear debris can have an effect on the local
periprosthetic tissue. In one of the only long-term studies
of retrieved explanted TDR tissue, Kurtz et al. noted a
chronic inflammatory response in the periprosthetic fibrous
tissues from 15 of 16 patients who had undergone revision
lumbar surgery for removal of the TDR prosthetic. Examina-
tion of this tissue demonstrated lymphocytes, macrophages,
and giant cells, which all had ingested small polyethylene
particles. Greater implantation time was associated with
greater presence of wear debris and giant cells, accompanied
by inflammatory cytokines. Innervation and vascularization
were also noted in the tissue, suggestive of the development
of neuroinflammatory-induced pain in these TDR patients
[7, 48]. They concluded that wear debris from TDR initiated
a complex interaction within the periprosthetic tissue of the
spine and pointed to the subsequent inflammatory cascade as
a potential etiology of postoperative intractable pain even out
to 16 years from implantation.
Veruva et al. recently reviewed the literature with regard
to biomaterials that can affect wear on performance on TDR
[6]. They focused on implant wear and any periprosthetic
tissue inflammation as a response to implantation of the
prosthetic device. In their review of papers describing devices
and tissues after explanation, they found that wear-associated
complications may be specific to the biomaterial selection
for TDR. For metal-on-polymer prosthetics in the cervical
spine, small and large polymeric debris was generated which
triggered an innate immune response with nearby tissue
activation of macrophages and giant cells. For total hip
arthroplasties (THA), polyethylene wear and its subsequent
innate inflammatory response have been associated with
osteolysis, aseptic loosening, and clinical failure [6, 10, 38].
In the spine, vertebral osteolysis seems to be a rare event [71].
This is even after Punt et al. observed on the order of 1 billion
polyethylene particles per gram of explanted periprosthetic
tissues fromTDRpatients [7, 72].Metal-on-metal prosthetics
created small metallic wear debris which triggered an adap-
tive immune response of activated lymphocytes. This wear
process poses the risk of metallosis, pseudotumors, aseptic
vasculitis, and metal hypersensitivity [6, 49, 73, 74]. Fretting
and corrosion products were seen in some metal-on-metal
cervical TDR but their clinical effect was unclear [7, 75].
A tremendous soft tissue reaction has been observed
to occur in rare occasions with metal-on-metal implants.
Termed a pseudotumor, this adverse reaction can cause
significant mass effect on neighboring structures and in
the hip arthroplasty literature has been shown to cause
pain, nerve palsy, joint dislocation, metal hypersensitivity
reactions, and osteolysis [49, 76–78]. One case report on
a cervical device implanted investigationally described the
formation of pseudotumor at the C4-5 disc space extending
ventrally down to the midbody of C6 [73]. On explanation of
the implant, a large yellowish necrotic mass was discovered
extending down into the ventral spinal canal. Histology
demonstrated a large area of necrotic debris with prominent
lymphocytic infiltrate. The Medtronic Prestige ST artificial
disc is currently the only FDA-approved cervical TDR device
that utilizes a metal-on-metal design using stainless steel.
Metal hypersensitivity reactions after metal-on-metal
bearing device implantations are presumed to be due to type
IV-delayed hypersensitivities based on their immunohisto-
chemical features [56]. The inflammatory response seen is
chronic and composed of mononuclear phagocytes, without
an acute inflammatory character due to very few neutrophils
observed in the tissue. Some reports exist to suggest that
hypersensitivity to the metal-on-metal wear debris is the
underlying pathophysiology of failed implantation, though
evidence is conflicting [57, 79, 80]. Metal degradation wear
debris has not been noted so far to have been associated with
necrosis or tissue degeneration in the spine [7, 72].
5.3. Osteolysis. Long-term complications such as wear
debris-induced osteolysis are well documented in the large
joint arthroplasty literature [81–83]. Periprosthetic bone loss
following hip arthroplasty placement accounted for over 75%
of patients undergoing revision hip surgery in one study and
in many other studies accounts for greater than the sum of all
other complications [84, 85]. In most series beyond 10 years,
the reported prevalence of aseptic osteolysis of hip implants
is between 32 and 62% [51, 86–89].
There is also evidence to support this complication in
the cervical spine. The available literature at this time of
osteolysis in cervical TDR has not been robust enough to
draw conclusions for a predicted incidence of this long-
term condition beyond just several reported cases, both
infectious and aseptic [7, 83]. Hacker et al. reported 4 patients
with either the Bryan or Prestige LP discs who experienced
periprosthetic bone loss after a minimum of 4 years of
follow-up [83]. In one patient who was presumed to have
an infection, there was marked loss of vertebral body bone
with deformity. Review of the explanted device and tissue
was suggestive of a low virulence bacterial infection based on
the appearance of macrophages, but no agent was identified
and all cultures had resulted negative. Although they did
not identify any convincing evidence for osteolysis as a
cause for the bone loss in these patients, they acknowledged
that its potential must exist based on prior experience with
arthroplasty devices. Tumiala´n and Gluf also reported a case
of osteolysis with the ProDisc-C device in a patient who
developed progressive neck pain at 9 months of follow-up
[71]. Imaging at 9 and 15 months demonstrated a progressive
osteolytic process which prompted explanation and conver-
sion to an arthrodesis. Further follow-up after the arthrodesis
showed resolution of the osteolytic process and radiographic
fusion.
The most widely accepted mechanism of osteolysis
involves implant particulate wear debris of any material
which then promotes inflammation that causes long-term
tissue damage and bone erosion leading to implant loosening
[87, 90]. At the cellular level, proosteoclastic inflammatory
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mediators stimulate differentiation of osteoclasts which sub-
sequently mediate bone resorption leading to failure of the
prosthesis [67].
5.4. Adverse Events. Thecurrent literature is fairly sparsewith
regard to dedicated reports of adverse events after cervical
TDR that could be directly attributable to material wear,
immune response hypersensitivity, or osteolysis. Hacker et al.
reported on two patients who presented with neck pain due
to periprosthetic bone loss around their Bryan discs but could
not conclude definitively that the bone loss was from osteol-
ysis instead of another etiology [83]. Neither patient required
further intervention and one patient clinically improved at
1-year follow-up. Guyer et al. reported on one case of a
patient, implanted with a Kineflex-C (Spinal Motion Inc,
Mountainview, CA) cervical arthroplasty device, who was
subsequently found on CT-myelography to have a soft-tissue
mass causing canal stenosis [74]. The implant required a
reoperation for implant removal, arthrodesis, and soft tissue
mass resection. Analysis of the soft tissue mass suggested
a delayed-type hypersensitivity to metal that resulted in
the chronic inflammatory pseudotumor. Tumiala´n and Gluf
reported on one patient who was found to have progressive
vertebral body osteolysis after implantation of a ProDisc-
C that resulted in persistent radicular and axial neck pain
and required reoperation with removal of the implant and
arthrodesis at that level [71]. The patient’s pain improved
postoperatively and the authors concluded that the osteolysis
was likely due to an immune-mediatedmetal hypersensitivity
response which resolved upon removal of the implant. Zigler
et al., however, reported on the 5-year results of 103 patients
treated with the ProDisc-C and found no adverse events
related to polyethylene wear, osteolysis, or material failure
[91]. Likewise, Sasso et al. reported on the 4-year results of
242 patients treated with the Bryan disc and similarly found
that no arthroplasty device required removal for wear or
wear-related failure [92].The existing literaturewould suggest
that adverse events related to material wear are suitably rare,
although further research and follow-up are needed to better
delineate the risks of these occurrences.
5.5. Clinical Evaluation. Maintaining a high level of clinical
suspicion for the adverse biological effects of material wear is
important for diagnosis and treatment.The proinflammatory
cascade that results from significant wear debris may result
in a type of neuroinflammatory-induced pain at the site
of the prosthesis that may be severe enough to necessitate
removal of the implant. This inflammatory process may
also cause pseudotumor formation that, if large enough,
can lead to the clinical spectrum and manifestations of
cervical radiculopathy or myelopathy. Both pseudotumor
and osteolysis can cause implant loosening and hardware
failure, which will possibly lead to segmental instability
and axial mechanical pain. Persistent postoperative neck or
arm pain should prompt further evaluation with dynamic
radiographs, CT, or MRI to allow for further workup of these
material-related complications. Knowledge of these potential
clinical findings in routine follow-upwill assist the surgeon in
capturing these complications early for further management
and surgical treatment as needed.
6. Conclusion
Cervical TDR is a motion-sparing operation that provides
a surgical alternative to fusion for selecting patients with
cervical radiculopathy ormyelopathy. Knowledge and under-
standing of the variety of biomaterials available will ensure
the continued development of safe and effective prosthetics
with increased longevity and decreased biological effects over
a lifetime. An appreciation of material wear characteristics
will help the surgeon maintain a high clinical suspicion
of postoperative clinical manifestations of material-related
biological effects.
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